Ifp Advisors, Inc Paratek Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change
Q3 2021 Oct 06, 2021	SELL	$4.7 - $7.24 $0 - $0	0 Closed
Q2 2021 Jul 13, 2021	BUY	$6.81 - $10.93 $0 - $0	0 New
Q1 2021 Apr 30, 2021	BUY	$6.14 - $8.31 $0 - $0	0 New
Q4 2020 Jan 25, 2021	BUY	$4.58 - $7.14 $0 - $0	0 New
Q3 2020 Oct 29, 2020	BUY	$4.19 - $6.69 $0 - $0	0 New

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.